ERYTHROMYCIN CAPSULES USP 250MG DIN 02235885
Health Canada record
| Active ingredient(s) | ERYTHROMYCIN 250 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01FA01 ERYTHROMYCIN |
| Original market date | |
| Current status date | 09-Apr-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Laboratoires K.A.B.S. Inc. — licence 100681, currently licensed, last inspection rating C (2026-06-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ERYTHROMYCIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02225271 | BENZAMYCIN | BAUSCH HEALTH, CANADA INC. | Gel | ERYTHROMYCIN 3 %; BENZOYL PEROXIDE 5 % | Marketed |
| 02141574 | ERYTHROMYCIN | PHARMA STULLN INC. | Ointment | ERYTHROMYCIN 5 MG | Marketed |
| 02326663 | ERYTHROMYCIN OPHTHALMIC OINTMENT USP | STERI-MED PHARMA INC. | Ointment | ERYTHROMYCIN 5 MG | Marketed |
| 01912755 | PDP-ERYTHROMYCIN | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Ointment | ERYTHROMYCIN 5 MG | Marketed |
| 02492350 | PMS-ERYTHROMYCIN | PHARMASCIENCE INC | Ointment | ERYTHROMYCIN 5 MG | Approved |
| 00640263 | ALTI-ERYTHROMYCIN TAB 250MG USP | ALTIMED PHARMA INC. | Tablet (Enteric-Coated) | ERYTHROMYCIN 250 MG | Cancelled Post Market |
| 00030899 | EMYCIN ECT 250MG | THE UPJOHN COMPANY OF CANADA | Tablet (Enteric-Coated) | ERYTHROMYCIN 250 MG | Cancelled Post Market |
| 00893862 | ERYBID | AMDIPHARM LIMITED | Tablet | ERYTHROMYCIN 500 MG | Cancelled Post Market |
| 00873454 | ERYC DELAYED-RELEASE CAPSULES | PFIZER CANADA ULC | Capsule (Enteric-Coated) | ERYTHROMYCIN 333 MG | Cancelled Post Market |
| 00607142 | ERYC DELAYED-RELEASE CAPSULES | PFIZER CANADA ULC | Capsule (Enteric-Coated) | ERYTHROMYCIN 250 MG | Cancelled Post Market |
| 02237041 | ERYMYCIN OPHTHALMIC OINTMENT 5MG/G | MM THERAPEUTICS INC | Ointment | ERYTHROMYCIN 5 MG | Cancelled Post Market |
| 02034506 | ERYSOL | GLAXOSMITHKLINE INC | Gel | ERYTHROMYCIN 2 %; ALCOHOL ANHYDROUS 75 %; OCTINOXATE 7.5 %; AVOBENZONE 2 % | Cancelled Post Market |
| 00532290 | ERYTHRO 200 | P.V.U., DIVISION OF VÉTOQUINOL N.-A. INC. | Liquid | ERYTHROMYCIN 200 MG | Cancelled Post Market |
| 00532266 | ERYTHRO 36 | P.V.U., DIVISION OF VÉTOQUINOL N.-A. INC. | Liquid | ERYTHROMYCIN 50 MG | Cancelled Post Market |
| 02172690 | ERYTHRO-200 (STERILE INJECTION) | VETOQUINOL N A INC | Solution | ERYTHROMYCIN 200 MG | Cancelled Post Market |
| 02172607 | ERYTHRO-36 - LIQ IMM 50MG/ML | VETOQUINOL N A INC | Solution | ERYTHROMYCIN 50 MG | Cancelled Post Market |
| 00682020 | ERYTHRO-BASE | AA PHARMA INC | Tablet | ERYTHROMYCIN 250 MG | Dormant |
| 00704385 | ERYTHRO-BASE TAB 250MG USP | PRO DOC LIMITEE | Tablet | ERYTHROMYCIN 250 MG | Cancelled Post Market |
| 02172615 | ERYTHRO-DRY COW - LIQ IMM 50MG/ML | P.V.U., DIVISION OF VÉTOQUINOL N.-A. INC. | Solution | ERYTHROMYCIN 50 MG | Cancelled Post Market |
| 00726672 | ERYTHRO-EC | AA PHARMA INC | Capsule (Enteric-Coated) | ERYTHROMYCIN 250 MG | Cancelled Post Market |
| 01925938 | ERYTHRO-EC | AA PHARMA INC | Capsule (Enteric-Coated) | ERYTHROMYCIN 333 MG | Cancelled Post Market |
| 00244635 | ERYTHROMID TAB 250MG | ABBOTT LABORATORIES, LIMITED | Tablet | ERYTHROMYCIN 250 MG | Cancelled Post Market |
| 02212935 | ERYTHROMYCIN OPHTHALMIC OINTMENT U.S.P. | RIVEX OPHTHALMICS INC. | Ointment | ERYTHROMYCIN 5 MG | Cancelled Post Market |
| 02460211 | EURO-ERYTHROMYCIN OPHTHALMIC OINTMENT USP | EURO-PHARM INTERNATIONAL CANADA INC | Ointment | ERYTHROMYCIN 5 MG | Cancelled Pre Market |
| 00595055 | GALLIMYCIN 100 INJ 100MG/ML | P.V.U., DIVISION OF VÉTOQUINOL N.-A. INC. | Liquid | ERYTHROMYCIN 100 MG | Cancelled Post Market |
| 00531987 | GALLIMYCIN 200 INJ | A.P.A., DIVISION OF VÉTOQUINOL N.-A. INC. | Liquid | ERYTHROMYCIN 200 MG | Cancelled Post Market |
| 00532037 | GALLIMYCIN 36 INJ 50MG/ML | A.P.A., DIVISION OF VÉTOQUINOL N.-A. INC. | Liquid | ERYTHROMYCIN 50 MG | Cancelled Post Market |
| 02172674 | GALLIMYCIN-200 (USP STERILE ERYTHROMYCIN INJECTION) | VETOQUINOL N A INC | Solution | ERYTHROMYCIN 200 MG | Cancelled Post Market |
| 02172682 | GALLIMYCIN-36 | VETOQUINOL N A INC | Solution | ERYTHROMYCIN 50 MG | Cancelled Post Market |
| 00878669 | NOVO-RYTHRO ENCAP 250MG | NOVOPHARM LIMITED | Capsule (Enteric-Coated) | ERYTHROMYCIN 250 MG | Cancelled Post Market |
| 00641324 | ODAN-ERYTHROMYCIN | ODAN LABORATORIESLTD | Ointment | ERYTHROMYCIN 5 MG | Dormant |
| 00769991 | PCE | AMDIPHARM LIMITED | Tablet | ERYTHROMYCIN 333 MG | Cancelled Post Market |
| 01902628 | SANS-ACNE SOLUTION | GALDERMA CANADA INC. | Solution | ERYTHROMYCIN 2 %; ALCOHOL ANHYDROUS 44 % | Cancelled Post Market |
| 01910086 | STATICIN LOT | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Lotion | ERYTHROMYCIN 1.5 %; ALCOHOL ANHYDROUS 55 %; LAURETH 4 6 % | Cancelled Post Market |
| 02047802 | T-STAT LOT | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Lotion | ERYTHROMYCIN 2 %; ALCOHOL ANHYDROUS 71.2 % | Cancelled Post Market |
| 02047799 | T-STAT PAD-LOT | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Pad; Lotion | ERYTHROMYCIN 2 %; ALCOHOL ANHYDROUS 71.2 % | Cancelled Post Market |
International API supply for ERYTHROMYCIN
7 valid EDQM Certificates of Suitability from 6 holders. 36 active FDA Drug Master Files.
Request a quote for ERYTHROMYCIN CAPSULES USP 250MG